China alleges British drug maker GlaxoSmithKline bribed Chinese doctors. But so does everyone else, say longtime observers. Why is China singling out GSK?

One of the Vivus' latest tactics is to market its drug straight to consumers. Starting this fall, you'll see Qsymia ads in magazines and on television. But it may still be too expensive for some.

China’s security ministry claims executives of the British drug company GlaxoSmithKline have confessed to bribery charges.

Nationwide drug shortages are causing hospitals to ration critical nutrients premature babies and other patients need to survive.

The prescription drug plan has created millions of senior customers for the pharmaceutical industry over ten years.

Viagra is one of the most-counterfeited drugs on the web, and Pfizer's latest effort to tackle that issue is a first.

Biogen Idec CEO George Scangos discusses his company's new multiple sclerosis drug, pricing strategy, and research process.

India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.

The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.

A new drug, in the final stages of approval by the FDA, could make it easier to give addicts medication without using pills and risking abuse.